SPARC and neoplasm: Through these receptors, albumin nanoparticles are internalised to the tumour interstitium, where they bind to secreted acidic proteins rich in cysteine (SPARC) that are overexpressed in many tumours, such as lung, breast, and pancreatic carcinomas [50,51].